Takeda Pharmaceutical
TAK
$13.06
Share price
-1.28%
Change (1 day)
-22.54%
Change (1 year)
Categories
Takeda Pharmaceutical (TAK) Fails to deliver data
Key failure to deliver metrics for Takeda Pharmaceutical:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $7.78 M
- Last 3 months FTD volume: $17.72 M
- Last year FTD volume: $78.77 M
Failures to deliver for Takeda Pharmaceutical (TAK) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Takeda Pharmaceutical (TAK) - since 2013
Volume in USD (price x number of shares), data since 2013Takeda Pharmaceutical (TAK) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $17.72 M | -85.29% |
| 2023 | $0.12 B | 113.2% |
| 2022 | $56.53 M | -68.82% |
| 2021 | $0.18 B | 692.67% |
| 2020 | $22.87 M | -91.87% |
| 2019 | $0.28 B | -34.7% |
| 2018 | $0.43 B | 582.42% |
| 2017 | $63.16 M | 35.85% |
| 2016 | $46.49 M | 196.68% |
| 2015 | $15.67 M | 54.27% |
| 2014 | $10.15 M | 537.98% |
| 2013 | $1.59 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.60 B | 🇺🇸 USA |
 Novartis NVS | $30.53 M | $95.22 M | 🇨🇭 Switzerland |
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 Sanofi SNY | $26.25 M | $54.4 M | 🇫🇷 France |
 Merck MRK | $8.48 M | $0.18 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Seagen
SGEN | N/A | $38.78 M | 🇺🇸 USA |
 Dr. Reddy's RDY | $2.87 M | $15.07 M | 🇮🇳 India |